Magliacano Marc
Known title: DirectorCIK: 0001770264
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Leslie's Announces Chapter 11 Plan for 90% Debt Cut. Leslie's Inc. disclosed a Chapter 11 restructuring plan aimed at reducing debt by 90% and securing $150 million in new capital. This corporate action coincided with a sharp 23% surge in the stock's after-hours trading. The move comes as the stock trades near its 52-week low, reflecting the significant financial restructuring underway.
Transaction History
| OSW | ▲ Buy | Grant | 7,993 | $0 | 7/22/2026 | View on chart |
| OSW | ▲ Buy | Grant | 9,385 | $0 | 7/23/2025 | View on chart |
| OSW | ▲ Buy | Grant | 12,127 | $0 | 7/23/2024 | View on chart |
| OSW | ▲ Buy | Grant | 12,606 | $0 | 7/26/2023 | View on chart |
| LESL | ▲ Buy | Option Exercise | 6,098 | $0 | 3/15/2023 | View on chart |
| OSW | ▲ Buy | Grant | 21,429 | $0 | 7/26/2022 | View on chart |
| LESL | ▲ Buy | Option Exercise | 2,207 | $0 | 3/16/2022 | View on chart |
| LESL | ▲ Buy | Option Exercise | 7,353 | $0 | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Cedar Grove Capital adds OSW to Q3 2026 portfolio
OneSpaWorld appears in Cedar Grove Capital’s Q3 2026 portfolio update released on SeekingAlpha. The inclusion signals that the fund’s manager is monitoring the stock as part of its investment process. This comes as the company trades near its 52‑week high and has an average analyst target of $31.20, above the current price range.
Cedar Grove Capital adds OSW to Q3 2026 portfolio. OneSpaWorld appears in Cedar Grove Capital’s Q3 2026 portfolio update released on SeekingAlpha. The inclusion signals that the fund’s manager is monitoring the stock as part of its investment process. This comes as the company trades near its 52‑week high and has an average analyst target of $31.20, above the current price range.